Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets

Area of Science:

• Immunology
• Infectious Diseases
• Malariology

Background:

• Variant surface antigens (VSAs) are key to severe malaria.
• Understanding immunity gaps in children is crucial for severe malaria pathogenesis.
• Immunity to Plasmodium falciparum antigens influences disease severity.

Purpose of the Study:

• Define immunity gaps to Plasmodium falciparum antigens in children with severe malaria.
• Improve understanding of severe malaria vulnerability and protective immunity development.
• Identify specific VSAs for vaccine development and diagnostics.

Main Methods:

• Utilized a protein microarray platform with 179 VSA variants and over 300 other blood-stage P. falciparum antigens.
• Measured antibody reactivity in sera from Malian children with cerebral malaria, severe malarial anemia, and age-matched controls.
• Analyzed seroreactivity profiles to identify differences in immune responses.

Main Results:

• Children with severe malaria recognized fewer extracellular PfEMP1 fragments compared to controls.
• Convalescent sera showed increased reactivity to non-CD36 binding PfEMP1s post-recovery.
• Severe malarial anemia patients had fewer VSA reactivities than cerebral malaria patients, with shared immunity gaps.

Conclusions:

• Microarray analysis reveals significant differences in VSA recognition between severe malaria patients and controls.
• Identified specific immunity lacunae in children affected by severe malaria.
• This approach can inform the development of effective vaccines and predictive diagnostics for severe malaria.